TSSI files Form 144 for 2,917 vested shares sale via Morgan Stanley
Rhea-AI Filing Summary
TSS, Inc. (TSSI) filed a Form 144 reporting a proposed sale of 2,917 common shares with an aggregate market value of $47,338.24. The shares were acquired on 06/27/2025 through restricted stock vesting under a registered plan for services rendered and are to be sold through Morgan Stanley Smith Barney on NASDAQ with an approximate sale date of 08/27/2025. The filing reports 25,364,244 shares outstanding, and no other sales in the past three months were reported. The filer certifies no undisclosed material adverse information is known.
Positive
- Shares were acquired via restricted stock vesting, indicating the issuance was compensation for services rather than a market purchase
- Filed with broker and planned sale date, providing transparent compliance with Rule 144 requirements
- Sale size is small relative to outstanding shares (~0.0115%), suggesting limited market impact
Negative
- Proposed insider sale reduces insider-held shares, which some investors may view negatively despite small size
Insights
TL;DR: Routine insider sale from vested restricted stock; size is immaterial to capitalization.
The filing documents a scheduled sale of 2,917 vested shares valued at $47,338.24, representing roughly 0.0115% of the company’s reported 25,364,244 outstanding shares. Acquisition via restricted stock vesting indicates the shares were compensation for services rather than a market purchase. Given the small size relative to outstanding shares and no other recent sales reported, the transaction is unlikely to move market valuations or signal a major change in insider conviction.
TL;DR: Disclosure follows Rule 144 mechanics; shows compensation-related issuance and compliant planned sale.
The notice provides required Rule 144 disclosure: broker, share count, acquisition date, nature of acquisition (restricted stock vesting), and statement regarding material nonpublic information. This aligns with standard governance and SEC compliance practices for insider sales tied to compensation. The absence of other sales in the prior three months simplifies aggregation rules and supports the filing’s procedural normality.